Pertento Partners LLP Has $7.33 Million Stock Holdings in Core Scientific, Inc. (NASDAQ:CORZ)

Pertento Partners LLP trimmed its holdings in Core Scientific, Inc. (NASDAQ:CORZ - Free Report) by 69.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 521,738 shares of the company's stock after selling 1,181,464 shares during the period. Core Scientific accounts for about 0.6% of Pertento Partners LLP's portfolio, making the stock its 23rd biggest holding. Pertento Partners LLP owned approximately 0.19% of Core Scientific worth $7,330,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the business. Orion Portfolio Solutions LLC bought a new position in Core Scientific in the 4th quarter valued at about $176,000. Pictet Asset Management Holding SA boosted its stake in Core Scientific by 49.1% in the 4th quarter. Pictet Asset Management Holding SA now owns 27,193 shares of the company's stock valued at $382,000 after purchasing an additional 8,960 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in Core Scientific in the 4th quarter valued at $241,000. Banco BTG Pactual S.A. bought a new position in Core Scientific during the 4th quarter worth $351,000. Finally, Cruiser Capital Advisors LLC lifted its holdings in shares of Core Scientific by 15.5% during the fourth quarter. Cruiser Capital Advisors LLC now owns 74,458 shares of the company's stock worth $1,046,000 after buying an additional 10,000 shares in the last quarter.

Core Scientific Stock Down 0.4 %

Shares of CORZ stock traded down $0.03 during mid-day trading on Wednesday, reaching $7.97. 14,292,953 shares of the stock traded hands, compared to its average volume of 11,724,316. The company has a market cap of $2.34 billion, a price-to-earnings ratio of -1.47 and a beta of 6.83. The stock's fifty day simple moving average is $10.58 and its two-hundred day simple moving average is $13.08. Core Scientific, Inc. has a 1-year low of $2.61 and a 1-year high of $18.63.

Remove Ads

Core Scientific (NASDAQ:CORZ - Get Free Report) last posted its earnings results on Wednesday, February 26th. The company reported ($0.01) earnings per share for the quarter, topping analysts' consensus estimates of ($0.10) by $0.09. The business had revenue of $94.93 million for the quarter, compared to the consensus estimate of $97.07 million. On average, equities research analysts anticipate that Core Scientific, Inc. will post 0.52 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Director Jordan Levy acquired 62,500 shares of the business's stock in a transaction that occurred on Thursday, March 6th. The shares were bought at an average cost of $8.01 per share, with a total value of $500,625.00. Following the completion of the purchase, the director now directly owns 306,887 shares in the company, valued at $2,458,164.87. The trade was a 25.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this link. Also, Director Todd A. Becker sold 134,250 shares of the stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $10.75, for a total transaction of $1,443,187.50. Following the sale, the director now directly owns 195,687 shares of the company's stock, valued at $2,103,635.25. This represents a 40.69 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 748,282 shares of company stock valued at $10,978,104. 32.00% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of equities analysts recently commented on CORZ shares. HC Wainwright reaffirmed a "buy" rating and set a $17.00 price target on shares of Core Scientific in a research report on Tuesday, March 11th. Canaccord Genuity Group restated a "buy" rating and set a $17.00 price objective on shares of Core Scientific in a research note on Wednesday, March 12th. BTIG Research lifted their price objective on Core Scientific from $19.00 to $20.00 and gave the company a "buy" rating in a report on Monday, December 16th. Keefe, Bruyette & Woods assumed coverage on Core Scientific in a research note on Monday, January 27th. They issued an "outperform" rating and a $22.00 price target for the company. Finally, Compass Point reduced their price objective on shares of Core Scientific from $26.00 to $20.00 and set a "buy" rating on the stock in a research note on Tuesday, February 25th. Fifteen investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Core Scientific currently has an average rating of "Buy" and a consensus price target of $19.07.

About Core Scientific

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.